VivaZome to collaborate with ANU retinal disease experts develop exosome-based therapies

VivaZome Therapeutics Pty Ltd is delighted to be collaborating with researchers at the Australian National University (ANU) and other expert groups focussing on improved therapies for age-related macular degeneration (AMD). The project entitled “The use of extracellular vesicles (EVs) for therapeutic RNA delivery as a novel treatment for retinal degenerations” is supported by a grant from ANU under its Research Support Program 2022, and includes researchers from the ANU School of Medicine and Psychology, VivaZome, Canberra Health Services, Sydney University, Save Sight Institute, La Trobe University and Flinders University. See more here